High-risk admission prior to transcatheter aortic valve implantation and subsequent outcomes

26 August 2023 (15:15 - 15:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Jarl Emanuel Strange

Herlev and Gentofte Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail

Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?

Doctor V. Panoulas (Harefield, Uxbridge, GB)

Abstract Slides Video

Presentation thumbnail

Impact of platelet reactivity on subclinical valve thrombosis in patients treated with TAVR

Doctor P. Jimenez-Quevedo (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation

Doctor D. Hesselbarth (Freiburg, DE)

Abstract Slides Video

Presentation thumbnail

Impact of visceral adipose tissue on mortality in patients undergoing transcatheter aortic valve implantation

Doctor A. Somaschini (Savona, IT)

Abstract Slides Video

Presentation thumbnail

Coronary angiography and intervention after transcatheter aortic valve implantation (TAVI): the nationwide SWEDEHEART registry

Doctor K. Nilsson (Uppsala, SE)

Abstract Slides Video

Access the full session

Session thumbnail

TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

The Event

Event poster

ESC Congress 2023

26 August 2023 15:15 CET

You may be interested in

Congress Presentation

NT-pro-BNP pre TAVI and relationship with long-term outcomes

Congress Session

Predictors of outcomes in transcatheter aortic valve implantation

Congress Session

Improving prognosis after TAVI

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources